Hepatoren (ifetroban) / Cumberland - LARVOL DELTA

Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) (clinicaltrials.gov) - P2; N=76; Recruiting; Sponsor: Cumberland Pharmaceuticals; Not yet recruiting ➔ Recruiting

Enrollment open • Asthma • Biosimilar • Immunology • Respiratory Diseases

Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients (clinicaltrials.gov) - P2; N=30; Not yet recruiting; Sponsor: Cumberland Pharmaceuticals

New P2 trial • Biosimilar • Cardiovascular • Fibrosis • Immunology